The immunology of Epstein-Barr virus-induced disease

Clicks: 414
ID: 272210
2015
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Epstein-Barr virus (EBV) is usually acquired silently early in life and carried thereafter as an asymptomatic infection of the B lymphoid system. However, many circumstances disturb the delicate EBV-host balance and cause the virus to display its pathogenic potential. Thus, primary infection in adol …
Reference Key
gs2015annualthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Taylor GS;Long HM;Brooks JM;Rickinson AB;Hislop AD;;
Journal annual review of immunology
Year 2015
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/25706097
Keywords
immunity National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't herpesvirus 4 immunocompromised host human / immunology* human / physiology carrier state innate adaptive immunity epstein-barr virus infections / complications* epstein-barr virus infections / diagnosis pmid:25706097 doi:10.1146/annurev-immunol-032414-112326 graham s taylor heather m long andrew d hislop epstein-barr virus infections / immunology* epstein-barr virus infections / virology immunologic deficiency syndromes / etiology lymphoproliferative disorders / etiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.